查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683383

全球呼吸器市场 - 2025-2033

Global Ventilators Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球呼吸器市场规模达到 60.6 亿美元，预计到 2033 年将达到 183.5 亿美元，2025-2033 年预测期内的复合年增长率为 11.7%。

全球呼吸器市场在呼吸护理中至关重要，为患有慢性阻塞性肺病、肺炎和急性呼吸窘迫综合征等疾病的患者提供救生支持。它根据移动性、类型、介面和最终用户进行细分，其中重症监护和便携式呼吸机是主要类别。飞利浦医疗、美敦力和通用电气医疗等领先公司占据市场主导地位，而 SCHILLER Healthcare 和 Ventis Medical Inc. 等新兴公司则推出了创新解决方案。由于技术进步、呼吸系统疾病的增加以及对非侵入性通气的需求不断增长，市场持续扩大。

市场动态：

驱动因素与约束因素

呼吸系统疾病发生率上升

全球呼吸器市场受到慢性阻塞性肺病、气喘、急性呼吸窘迫症候群和肺炎等呼吸系统疾病发病率上升的推动，而空气污染、吸烟和人口老化等因素则推动了这一市场的发展。 COVID-19 疫情凸显了医院、家庭护理和紧急护理对呼吸机的需求，从而加速了市场成长并解决了严重的呼吸窘迫。

例如，根据 NCD 联盟的数据，慢性呼吸道疾病 (CRD) 是与肺部相关的疾病，在世界各地导致大量发病率和死亡率。常见的慢性阻塞性肺病 (CRD) 包括慢性阻塞性肺病 (COPD)、气喘、肺癌和职业性肺病。这些疾病影响全球至少 5,500 亿成年人，占所有死亡人数的 7%。肺癌每年导致另外14亿人死亡。

五岁以下的儿童特别容易受到肺部疾病的影响，包括肺炎等急性传染病和气喘等慢性病。气喘是最常见的慢性病，​​影响全球 14% 的儿童。此外，根据美国疾病管制与预防中心的报告，2024 年 10 月 1 日至 11 月 30 日期间，因 RSV 住院的人数为 17,000 至 34,000 人。

严格的监管环境和合规要求

呼吸器市场面临严格的监管框架、广泛的测试、临床试验和认证流程的挑战，这可能会延迟上市时间并增加成本。製造商必须适应不断发展的标准，这可能会阻碍创新并使产品发布复杂化，从而抑制市场成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 呼吸系统疾病发生率上升
      • 科技进步的崛起
    • 限制
      • 严格的监管环境和合规要求
      • 新兴地区医疗基础设施有限
    • 机会
      • 居家护理通风设备的扩展
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 管道分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：按类型

  • 成人呼吸器
    • 儿科呼吸机
    • 新生儿/婴儿呼吸器
  • 按移动方式
  • 重症监护呼吸机
  • 便携式/可移动式呼吸机

第 7 章：按介面

  • 侵入性通气
  • 非侵入性通气

第 8 章：按最终用户

  • 医院和诊所
  • 家庭护理设置
  • 门诊护理中心
  • 紧急医疗服务（EMS）

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Philips Healthcare
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • ResMed Inc
  • Medtronic plc
  • GE Healthcare
  • Dragerwerk AG & Co. KGaA
  • Hamilton Medical AG
  • Fisher & Paykel Healthcare Corporation Limited
  • Getinge AB
  • Vyaire Medical
  • AgVa Healthcare
  • Similar data will be provided for each market player.
  • SCHILLER Healthcare India 私人有限公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • Biovo 技术有限公司
  • 布雷斯医疗公司
  • Enexor 生物能源有限责任公司
  • 将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录
Product Code: MD9321

The global ventilators market reached US$ 6.06 billion in 2024 and is expected to reach US$ 18.35 billion by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.

The global ventilators market is vital in respiratory care, providing life-saving support to patients with conditions like COPD, pneumonia and ARDS. It is segmented based on mobility, type, interface, and end-users, with intensive care and portable ventilators being key categories. Leading companies like Philips Healthcare, Medtronic and GE Healthcare dominate the market while emerging players like SCHILLER Healthcare and Ventis Medical Inc. introduce innovative solutions. The market continues to expand due to technological advancements, rising respiratory diseases, and the growing demand for non-invasive ventilation.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Respiratory Diseases

The global ventilators market is driven by the rise in respiratory diseases like COPD, asthma, ARDS, and pneumonia, driven by factors like air pollution, smoking, and aging populations. The COVID-19 pandemic underscored the need for ventilators in hospitals, home care, and emergency care, accelerating market growth and addressing severe respiratory distress.

For instance, according to the NCD Alliance, Chronic respiratory diseases (CRDs) are lung-related diseases that cause significant morbidity and mortality worldwide. Common CRDs include COPD, asthma, lung cancer, and occupational lung diseases. These diseases affect at least 550 Billion adults globally and account for 7% of all deaths. Lung cancer contributes to another 1.4 Billion deaths annually.

Children under five years of age are particularly affected by lung diseases, including acute infectious diseases like pneumonia and chronic conditions like asthma. Asthma is the most common chronic condition, affecting 14% of children globally. Moreover, according to the Centers for Disease Control and Prevention reports between October 1 and November 30, 2024, there were between 17,000 and 34,000 hospitalizations due to RSV.

Stringent Regulatory Environment and Compliance Requirements

The ventilators market faces challenges due to strict regulatory frameworks, extensive testing, clinical trials, and certification processes, which can delay time-to-market and increase costs. Manufacturers must adapt to evolving standards, which can hinder innovation and complicate product launches, restraining market growth.

Segment Analysis

The global ventilators market is segmented based on type, mobility, interface, end user and region.

Type:

The adult ventilators in the type segment are expected to dominate the ventilators market with the highest market share

Adult ventilators are mechanical devices used to provide respiratory support to adults with breathing difficulties or respiratory failure. They deliver controlled oxygen and remove carbon dioxide, ensuring adequate gas exchange in the lungs. Commonly used in ICUs, emergency rooms, and home care for conditions like COPD, ARDS, and post-surgical recovery.

The adult ventilator market is fueled by rising respiratory diseases like COPD, ARDS, and pneumonia, as well as the geriatric population's increased susceptibility to respiratory illnesses. Moreover, product launches, technological advancements like AI integration and the development of portable and home-use ventilators are driving market growth. The increasing number of ICU admissions, awareness of critical care infrastructure, and government initiatives to strengthen healthcare systems, particularly after the COVID-19 pandemic, are also driving market expansion.

For instance, in February 2024, Getinge launched its Sewo-c mechanical ventilator in India, designed to cater to the diverse respiratory needs of both pediatric and adult patients. The launch is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India.

Geographical Analysis

North America is expected to hold a significant position in the ventilators market with the highest market share

North America is experiencing significant growth in the ventilators market due to its advanced healthcare infrastructure, significant medical technology investment, and high demand for respiratory care solutions. Government initiatives and reimbursement policies support advanced ventilator systems, especially in critical care settings. The COVID-19 pandemic has accelerated investments in intensive care infrastructure, emphasizing the need for reliable ventilator support.

The presence of major players in the region is focussing on product launches with advancements, driving the market growth in the region. For instance, in October 2024, Nihon Kohden America, a global medical technology leader, introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.

Competitive Landscape

The major global players in the ventilators market include Philips Healthcare, ResMed Inc., Medtronic plc, GE Healthcare, Dragerwerk AG & Co. KGaA, Hamilton Medical AG, Fisher & Paykel Healthcare Corporation Limited, Getinge AB, Vyaire Medical and AgVa Healthcare among others.

Key Developments

  • In November 2024, CorVent Medical received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, safe, and smart ventilation system designed to improve healthcare access for healthcare systems, providers, and patients.
  • In July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, developed in collaboration with the Angers University Hospital's intensive care unit, is a pioneering addition to the company's mechanical ventilation history. The ventilator is designed to provide superior comfort and efficiency in healthcare settings.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ventilators market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Interface
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Environment and Compliance Requirements
      • 4.1.2.2. Limited Healthcare Infrastructure in Emerging Regions
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion in Homecare Ventilation
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Adult Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Pediatric Ventilators
    • 6.2.4. Neonatal/Infant Ventilators
  • 6.3. By Mobility
  • 6.4. Introduction
    • 6.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 6.4.2. Market Attractiveness Index, By Mobility
  • 6.5. Intensive Care Ventilators*
    • 6.5.1. Introduction
    • 6.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.6. Portable/Transportable Ventilators

7. By Interface

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 7.1.2. Market Attractiveness Index, By Interface
  • 7.2. Invasive Ventilation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Invasive Ventilation

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Home Care Settings
  • 8.4. Ambulatory Care Centers
  • 8.5. Emergency Medical Services (EMS)

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Philips Healthcare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. ResMed Inc
  • 11.3. Medtronic plc
  • 11.4. GE Healthcare
  • 11.5. Dragerwerk AG & Co. KGaA
  • 11.6. Hamilton Medical AG
  • 11.7. Fisher & Paykel Healthcare Corporation Limited
  • 11.8. Getinge AB
  • 11.9. Vyaire Medical
  • 11.10. AgVa Healthcare
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. SCHILLER Healthcare India Private Limited*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Biovo Technologies Ltd.
  • 11.13. Breas Medical AB
  • 11.14. Enexor BioEnergy LLC
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us